145 related articles for article (PubMed ID: 18650832)
1. MAST3: a novel IBD risk factor that modulates TLR4 signaling.
Labbé C; Goyette P; Lefebvre C; Stevens C; Green T; Tello-Ruiz MK; Cao Z; Landry AL; Stempak J; Annese V; Latiano A; Brant SR; Duerr RH; Taylor KD; Cho JH; Steinhart AH; Daly MJ; Silverberg MS; Xavier RJ; Rioux JD
Genes Immun; 2008 Oct; 9(7):602-12. PubMed ID: 18650832
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide expression profiling implicates a MAST3-regulated gene set in colonic mucosal inflammation of ulcerative colitis patients.
Labbé C; Boucher G; Foisy S; Alikashani A; Nkwimi H; David G; Beaudoin M; Goyette P; Charron G; Xavier RJ; Rioux JD
Inflamm Bowel Dis; 2012 Jun; 18(6):1072-80. PubMed ID: 21994190
[TBL] [Abstract][Full Text] [Related]
3. MAST3 modulates the inflammatory response and proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.
Xu Q; Yin S; Yao Y; Li X; Song B; Yang Y; Liu Y; Chen R; Li J; Ma T; Meng X; Huang C; Li J
Int Immunopharmacol; 2019 Dec; 77():105900. PubMed ID: 31644963
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in German shepherd dogs.
Kathrani A; House A; Catchpole B; Murphy A; German A; Werling D; Allenspach K
PLoS One; 2010 Dec; 5(12):e15740. PubMed ID: 21203467
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic MAST3 Variants in the STK Domain Are Associated with Epilepsy.
Spinelli E; Christensen KR; Bryant E; Schneider A; Rakotomamonjy J; Muir AM; Giannelli J; Littlejohn RO; Roeder ER; Schmidt B; Wilson WG; Marco EJ; Iwama K; Kumada S; Pisano T; Barba C; Vetro A; Brilstra EH; van Jaarsveld RH; Matsumoto N; Goldberg-Stern H; Carney PW; Andrews PI; El Achkar CM; Berkovic S; Rodan LH; ; McWalter K; Guerrini R; Scheffer IE; Mefford HC; Mandelstam S; Laux L; Millichap JJ; Guemez-Gamboa A; Nairn AC; Carvill GL
Ann Neurol; 2021 Aug; 90(2):274-284. PubMed ID: 34185323
[TBL] [Abstract][Full Text] [Related]
6. Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium.
Mokry M; Middendorp S; Wiegerinck CL; Witte M; Teunissen H; Meddens CA; Cuppen E; Clevers H; Nieuwenhuis EE
Gastroenterology; 2014 Apr; 146(4):1040-7. PubMed ID: 24333384
[TBL] [Abstract][Full Text] [Related]
7. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
[TBL] [Abstract][Full Text] [Related]
8. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases.
De Jager PL; Franchimont D; Waliszewska A; Bitton A; Cohen A; Langelier D; Belaiche J; Vermeire S; Farwell L; Goris A; Libioulle C; Jani N; Dassopoulos T; Bromfield GP; Dubois B; Cho JH; Brant SR; Duerr RH; Yang H; Rotter JI; Silverberg MS; Steinhart AH; Daly MJ; Podolsky DK; Louis E; Hafler DA; Rioux JD; ;
Genes Immun; 2007 Jul; 8(5):387-97. PubMed ID: 17538633
[TBL] [Abstract][Full Text] [Related]
9. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
[TBL] [Abstract][Full Text] [Related]
10. ARPP-16 Is a Striatal-Enriched Inhibitor of Protein Phosphatase 2A Regulated by Microtubule-Associated Serine/Threonine Kinase 3 (Mast 3 Kinase).
Andrade EC; Musante V; Horiuchi A; Matsuzaki H; Brody AH; Wu T; Greengard P; Taylor JR; Nairn AC
J Neurosci; 2017 Mar; 37(10):2709-2722. PubMed ID: 28167675
[TBL] [Abstract][Full Text] [Related]
11. Increased Toll-like receptor 9 expression by B cells from inflammatory bowel disease patients.
Berkowitz D; Peri R; Lavy A; Kessel A
Hum Immunol; 2013 Dec; 74(12):1519-23. PubMed ID: 24007656
[TBL] [Abstract][Full Text] [Related]
12. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.
Kelsen JR; Dawany N; Moran CJ; Petersen BS; Sarmady M; Sasson A; Pauly-Hubbard H; Martinez A; Maurer K; Soong J; Rappaport E; Franke A; Keller A; Winter HS; Mamula P; Piccoli D; Artis D; Sonnenberg GF; Daly M; Sullivan KE; Baldassano RN; Devoto M
Gastroenterology; 2015 Nov; 149(6):1415-24. PubMed ID: 26193622
[TBL] [Abstract][Full Text] [Related]
13. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling.
Chen X; Liu G; Yuan Y; Wu G; Wang S; Yuan L
Cell Death Dis; 2019 Dec; 10(12):906. PubMed ID: 31787755
[TBL] [Abstract][Full Text] [Related]
14. Meeting summary: Signal transduction pathways in immune and inflammatory cells. November 30-December 3, 2000, Amelia Island, Florida, U.S.A.
Plevy S; Mayer L
Inflamm Bowel Dis; 2003 Jan; 9(1):28-33. PubMed ID: 12656135
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
[TBL] [Abstract][Full Text] [Related]
16. Association between Toll-like receptor 4 and inflammatory bowel disease.
Oostenbrug LE; Drenth JP; de Jong DJ; Nolte IM; Oosterom E; van Dullemen HM; van der Linde K; te Meerman GJ; van der Steege G; Kleibeuker JH; Jansen PL
Inflamm Bowel Dis; 2005 Jun; 11(6):567-75. PubMed ID: 15905704
[TBL] [Abstract][Full Text] [Related]
17. Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1.
O'Connell RM; Vaidya SA; Perry AK; Saha SK; Dempsey PW; Cheng G
J Immunol; 2005 Feb; 174(3):1602-7. PubMed ID: 15661922
[TBL] [Abstract][Full Text] [Related]
18. Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury.
Cairns B; Maile R; Barnes CM; Frelinger JA; Meyer AA
J Trauma; 2006 Aug; 61(2):293-8; discussion 298-9. PubMed ID: 16917441
[TBL] [Abstract][Full Text] [Related]
19. Regulatory Effects of Toll-like Receptor 4 Knockout on CD4
Ren Y; Wang R; Jiang L; Wang X; Feng Z; He J; He X; Du G
Ann Clin Lab Sci; 2020 Nov; 50(6):761-768. PubMed ID: 33334791
[TBL] [Abstract][Full Text] [Related]
20. CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases.
Wittig B; Seiter S; Schmidt DS; Zuber M; Neurath M; Zöller M
Lab Invest; 1999 Jun; 79(6):747-59. PubMed ID: 10378517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
